Healthcare Realty Trust Incorporated

Q2 normalized FFO per share was $0.41, same store cash NOI growth was 5.1%, and FAD per share was $0.32. The quarterly dividend payout ratio was 76%. The company executed 23 leases totaling 1.5 million square feet, including 350 thousand square feet of new leasing; same store cash leasing spreads averaged 4.8%, average escalators were 3%, tenant retention was 88.5%, and same store occupancy was nearly 93%. Management raised full-year normalized FFO per share guidance by $0.02 to $1.64 at the midpoint and to $1.66 at the top end, and increased same store cash NOI guidance to 4.25% to 5%. Uses of capital were increased by $115 million for the year, with disposition guidance raised by a similar amount.

Peter Scott framed the quarter as evidence that the one-year-old strategic plan is working, saying the company is outperforming every key objective. He emphasized improved occupancy, retention, leasing spreads, lower leverage, and a more disciplined capital allocation framework, while saying the company is “not satisfied” and is “not slowing down.” His tone was confident and assertive, with repeated emphasis on execution, partnerships with health systems, and the opportunity to scale the medical office platform.

Daniel Gabbay focused on the financial translation of the operating gains and balance sheet actions. He highlighted Q2 normalized FFO per share of $0.41, same store cash NOI growth of 5.1%, FAD per share of $0.32, and a 76% dividend payout ratio. He said the company issued $700 million of exchangeable notes at a 3% coupon, raised a $400 million delayed draw term loan, has $1.2 billion of liquidity on its line of credit, and can address maturities through 2027 with flexibility through 2029; he also noted the company repurchased $75 million of stock in the quarter and keeps leverage in the mid-5x area.

Analysts focused on how far ahead management is versus the prior strategic plan, the size and funding of the KKR JV opportunity, the redevelopment pipeline, and the Ascension transaction economics. Management said it feels ahead of schedule on the 2028 AFFO outlook, but declined to give an exact number; it described the KKR vehicle as attractive and disciplined, funded primarily through capital recycling and free cash flow rather than a broad equity-driven “flywheel.” On Ascension, management said the $35 million investment is tied to a 10-year lease extension, a double-digit mark-to-market, and potential NOI growth from about $7 million today to $10 million-plus over time. They also said the redevelopment pipeline could rise toward about 30 assets and that the current pipeline’s 9% to 12% return range is roughly in the middle today.